| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 4,914,489 shares worth roughly $168.8M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.12B | - | |
| 10% | 34.49M | $1.25B | - | |
| Pres | 18.68M | $678.74M | - | |
| CEO | 16.74M | $608.19M | - | |
| Dir | 13.69M | $497.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | Venker Eric | President &COO | Sell | 136,421 | $3.70 | $504,757.70 | -10.7% | +3.8% | +151.9% | |
| May 20, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 12,127 | $3.70 | $44,869.90 | -7.6% | +3.8% | +151.9% | |
| Apr 25, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 703 | $3.84 | $2,699.52 | -0.4% | +2.7% | +115.8% | |
| Apr 25, 2022 | Venker Eric | President &COO | Sell | 5,107 | $3.84 | $19,610.88 | -0.4% | +2.7% | +115.8% | |
| Apr 25, 2022 | Gline Matthew | CEO | Sell | 8,509 | $3.84 | $32,674.56 | -0.6% | +2.7% | +115.8% | |
| Apr 25, 2022 | Dexcel Pharma Technologies Ltd.79 | 10% Owner | Buy | 40,285 | $3.85 | $154,954.16 | - | +2.7% | +115.8% | |
| Mar 30, 2022 | Kumar Rakhi45 | Chief Accounting Officer | Sell | 2,486 | $4.84 | $12,032.24 | -1.5% | -0.8% | +54.2% | |
| Mar 30, 2022 | Gline Matthew | CEO | Sell | 33,686 | $4.84 | $163,040.24 | -2.3% | -0.8% | +54.2% | |
| Mar 30, 2022 | Venker Eric | President &COO | Sell | 19,336 | $4.84 | $93,586.24 | -1.5% | -0.8% | +54.2% | |
| Mar 25, 2022 | Venker Eric | President &COO | Sell | 80,045 | $5.06 | $405,027.70 | -5.8% | -6.4% | +39.0% |